Publication | Closed Access

Reduced Antidiabetic Effect of Metformin and Down-regulation of Hepatic Oct1 in Rats with Ethynylestradiol-Induced Cholestasis

Metabolic SyndromeEthynylestradiol-induced CholestasisHepatologyBiochemistryMedicineLiver PhysiologyDiabetesPhysiologyAntidiabetic EffectHepatotoxicityHepatic Oct1Liver DiseaseFatty Liver DiseaseMetabolismPharmacologyDrug-induced Liver InjuryOxidative StressHealth Sciences